Disease Profiles: Muscle Diseases Flashcards
What is myasthenia gravis?
Severe autoimmune neuromuscular disorder characterised by severe muscular weakness and progressive fatigue
What is MRI used for in suspected polymyositis or dermatomyositis?
Used to localise the extent of muscle involvement
Which patient group is most likely to develop myasthenia gravis?
Can occur at any age but usually presents at after middle age - most commonly 60-70
Which type of hypersensitivity is myasthenia gravis associated with?
Type II
What causes polymyositis and dermatomyositis?
CD8+ T cell mediated reaction against muscle antigens
Describe the management of tetanus
Surgical debridement, anti-toxin, supportive measures (e.g. benzodiasapines, beta blockers), 7-10 days antibiotics, booster vaccination
Name the two inflammatory myopathies
Polymyositis and dermatomyositis
Describe the non-pharmacological management of fibromyalgia
Education, graded exercise, CBT, complementary medicine e.g. acupuncture
Describe MRI changes seen in polymyositis or dermatomyositis
Muscle inflammation, oedema, fibrosis and calcification
What is polymyositis?
Idiopathic inflammatory myopathy that causes symmetrical, proximal muscle weakness
What is usually the first line treatment for myasthenia gravis (if not associated with a thymic tumour)?
Anticholinesterases
What is usually the second line treatment for myasthenia gravis (if not associated with a thymic tumour)?
Immunosuppressive drugs, corticosteriods
Which bacteria is associated with pyomyositis in contaminated wounds?
Clostridium
What are the antibodies associated with polymyositis and dermatomyositis?
Non-specific - ANA, anti-RNP
Myositis specific - Anti-Jo-1, anti-SRP
Name the enzymes normally raised in patients with polymyositis or dermatomyositis
Muscle enzymes e.g. creatine kinase
What is the definitive test for polymyositis or dermatomyositis?
Muscle biopsy
Describe the pathophysiology of myasthenia gravis
anti-AChR antibodies are generated in response to AChR subunits expressed by thymic myoid cells (via CD4+ TH cells and B cells)
The anti-AChR antibodies block the binding of ACh to the ACh receptors at the neuromuscular endplate
Endplate potential is not sufficient to trigger muscular contraction
Name a complication of polymyositis and dermatomyositis and name which patient group is most at risk
Increased risk of malignancy
Greatest risk in males > 45 years
Which is the most common causative organism for pyomyositis?
Staphlococci (90%)
Describe how tetanus can be prevented
Routine vaccination, good wound management
Describe the clinical presentation of polymyositis and dermatomyositis
Symmetrical, proximal muscle weakness in the upper and lower extremities, insidious onset and gets worse over months
Myalgia in 25-50%
Muscle wasting
Describe a positive muscle biopsy for polymyositis or dermatomyositis
Perivascular inflammation and muscle necrosis
What causes myasthenia gravis?
Autoimmune disorder - 90% idiopathic, 10% due to thymic tumour
Which patient group does polymyositis and dermatomyositis most commonly occur in?
Females age 40-50 years
What is pyomyositis?
Acute intramuscular infection secondary to haematogenous spread of the microorganism into the body of a skeletal muscle, most commonly caused by Staph. aureus
Name the gene complex associated with a genetic predisposition for myasthenia gravis
HLA associations